Effectors of the Type VI Secretion System Have the Potential to Be Modified into Antimicrobial Peptides
ABSTRACT The use of antibiotics has led to the emergence of multidrug-resistant (MDR) bacteria, and there is an urgent need to find alternative treatments to alleviate this pressure. The type VI secretion system (T6SS) is a protein delivery system present in bacterial cells that secretes effectors t...
Main Authors: | Wenjia Lu, Hao Lu, Chenchen Wang, Gaoyan Wang, Wenqi Dong, Chen Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2023-08-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00308-23 |
Similar Items
-
Secretory Peptides as Bullets: Effector Peptides from Pathogens against Antimicrobial Peptides from Soybean
by: Yee-Shan Ku, et al.
Published: (2020-12-01) -
A DNase Type VI Secretion System Effector Requires Its MIX Domain for Secretion
by: Chaya Mushka Fridman, et al.
Published: (2022-10-01) -
Structure-Based Prototype Peptides Targeting the Pseudomonas aeruginosa Type VI Secretion System Effector as a Novel Antibacterial Strategy
by: Xiaopan Gao, et al.
Published: (2017-09-01) -
Diversity and prevalence of type VI secretion system effectors in clinical Pseudomonas aeruginosa isolates
by: Luca A. Robinson, et al.
Published: (2023-01-01) -
The Antibacterial and Anti-Eukaryotic Type VI Secretion System MIX-Effector Repertoire in <i>Vibrionaceae</i>
by: Yasmin Dar, et al.
Published: (2018-11-01)